Clinical Trials Directory

Trials / Completed

CompletedNCT00627107

A Study Testing Safety and Tolerance of the ReWalk Exoskeleton Suit

Study of the ReWalk Motorized Exoskeleton Suit That Enables Individuals With Lower Limbs Impairment to Walk and to Perform Other Basic Mobility Functions.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
6 (estimated)
Sponsor
ReWalk Robotics, Inc. · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The ReWalk enables people with lower limb disabilities to carry out routine ambulatory functions (stand, walk, climb stairs etc.). It can be used by people with disabilities such as spinal cord injury, brain injury, stroke, multiple sclerosis, cerebral palsy and other severe walking impairments. The device promises to restore the dignity of disabled persons, enabling them to work and improve their general health and quality of life, as well as significantly reduce medical and other related expenses.

Detailed description

The ReWalk comprises light wearable brace support suit, which integrates DC motors at the joints, rechargeable batteries, an array of sensors and a computer-based control system. It is snugly fitted on the body and worn underneath the clothing, if desired. ReWalk is a new realization of the Powered Exoskeleton concept, first tried about fifty years ago with no success. Employing an innovative, non-robotic design approach, it uniquely matches the user's capabilities with the control mechanisms. Upper-body movements of the user are detected and used to initiate and maintain walking processes. User stability and safety during ambulation is secured by concurrent use of safety aids such as crutches for walking and railing for stairs.

Conditions

Interventions

TypeNameDescription
DEVICEReWalk - a motorized exoskeleton suitThe subject will wear the ReWalk suit and have training sessions for walking with the device.

Timeline

Start date
2008-02-01
Primary completion
2009-01-01
Completion
2009-01-01
First posted
2008-02-29
Last updated
2010-11-30

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00627107. Inclusion in this directory is not an endorsement.